Most active investors · Jul 19, 2026 – Oct 16, 2026
Ranked by rounds participated in, from announcements in Jul 19, 2026 – Oct 16, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Soteris Undisclosed SeedArintra $25M Series BDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
TERASi €11M SeedFreya Industries SEK 6M Funding roundDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Seed 1
StarSling Undisclosed Pre-SeedPharosyn $3M SeedDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 2
Nexstrom $12M SeedHang Ten Systems $53M Additional seed fundingDetails
Details
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
FintechOS $28M Funding roundNavVis $85M Series DDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Footprint $25M Series BKastle $24M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
AI Hospitality Group $7.5M SeedUNIT AI $12M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Paymob $35M Pre-Series CSportano €15M Growth equity investmentDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Productive Machines Undisclosed Growth investmentTickets for Good £3.9M Funding roundDetails
New companies 2 · Follow-on 0
Stages: Growth 1, Series C+ 1
Paymob $35M Pre-Series CEnhance $18.2M Equity and venture-debt roundDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
FintechOS $28M Funding roundARC Ride $33.3M FundingDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
ImpriMed $10M Series A2 bridgePoint2 Technology $136M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
FintechOS $28M Funding roundQureight $20M Series BDetails
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Novadip Biosciences €10.4M Convertible financingBrenus Pharma €11M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Novadip Biosciences €10.4M Convertible financingChift €10.5M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Nex >$150M Series E and new credit facilityMath Magic Undisclosed Series A+Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Arcos €5.5M SeedHyImpulse >€50M Series A extensionDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Robigo Undisclosed Series AEncoded Therapeutics Inc. $275M Series FDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Big Picture Bio £2.2M Pre-seed and Innovate UK grant packageEcoNomad Solutions £400K Investment and Innovate UK grantDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Tempo Therapeutics $14.5M FundingMoonwalk Biosciences $70M Series BDetails
New companies 1 · Follow-on 1
Stages: Series C+ 2
Impulse Space $308M Series D extensionHadrian $1.4B Series DDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 2
Arcee AI ≥$150M Series BPolaris Electro-Optics $50M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.